Biological E

Dr V K Paul said  by the first quarter of the next year, the number is likely to be three billion

The company plans to produce 75 million to 80 million doses a month from August

India has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the…

The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change,…

India is the world’s biggest maker of vaccines, and its companies have promised to produce billions of doses of COVID-19 shots

Biological E has said it can produce 600 million doses for J&J and more than one billion doses a year of its own vaccine,…

Zydus Cadila, Sputnik V, Biological E and Gennova are in advanced clinical trials in India, some of them likely to approach drug…

CEPI will initially contribute up to $5 million toward the cost of scaling up the process for manufacturing the vaccine, and will…

The timing of this acquisition is fortuitous as it will immediately allow us to expand our capacity to manufacture our…

The agreements are for Baylor's recombinant protein vaccine candidate and J&J's Ad26.COV2.S vaccine, currently in Phase 1/2…